Review article · 2026 · Open access
Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions
Frontiers in Endocrinology, 17, 1837504 · Published 4 June 2026 · DOI 10.3389/fendo.2026.1837504
In brief
“Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions” is a 2026 review article by Chuying Yu and 5 co-authors, published in Frontiers in Endocrinology. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Frontiers in Endocrinology.
- Citations
- 0
- References
- 88
- Authors
- 6
Abstract
Bile acids (BAs) serve dual roles as lipid-digesting molecules and key signaling mediators in metabolism and immune regulation. This review systematically examines: 1.the molecular mechanisms underlying BA-mediated regulation of glucolipid m5etabolism and energy expenditure; 2.host- and microbiota-driven BA modifications (e.g., 3-acylation); 3. therapeutic targeting of BA signaling pathways (FXR/TGR5). We highlight emerging strategies, including novel BA modifications, microbiota interventions, and BA-targeted therapies, which reshape BA homeostasis and show therapeutic potential for metabolic, digestive, hepatobiliary, and neoplastic diseases. Furthermore, we emphasize the central role of BA modifications in metabolic regulation and their pathological implications. Advances in multi-omics and AI-driven approaches deepen mechanistic insights and accelerate the translation of BA-based interventions into clinical practice. Most of the findings discussed in this review are derived from preclinical studies ( in vitro and animal models); clinical translation of bile
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Yu, C., Ye, X., Zhao, H., 钱素婷, Xie, F., & Liu, Q. (2026). Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions. Frontiers in Endocrinology, 17, 1837504. https://doi.org/10.3389/fendo.2026.1837504
MLA 9
Yu, Chuying, et al. “Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions.” Frontiers in Endocrinology, vol. 17, 2026, p. 1837504. https://doi.org/10.3389/fendo.2026.1837504.
Chicago
Yu, Chuying, Xintong Ye, Haoyu Zhao, 钱素婷, Feifei Xie, and Qingsheng Liu. 2026. “Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions.” Frontiers in Endocrinology 17: 1837504. https://doi.org/10.3389/fendo.2026.1837504.
Harvard
Yu, C. et al. (2026) ‘Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions’, Frontiers in Endocrinology, 17, p. 1837504. doi:10.3389/fendo.2026.1837504.
IEEE
C. Yu, X. Ye, H. Zhao, 钱素婷, F. Xie, and Q. Liu, “Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions,” Frontiers in Endocrinology, vol. 17, p. 1837504, 2026, doi: 10.3389/fendo.2026.1837504.
BibTeX
@article{yu2026bile,
title = {{Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions}},
author = {Yu, Chuying and Ye, Xintong and Zhao, Haoyu and 钱素婷 and Xie, Feifei and Liu, Qingsheng},
journal = {Frontiers in Endocrinology},
year = {2026},
volume = {17},
pages = {1837504},
doi = {10.3389/fendo.2026.1837504},
url = {https://doi.org/10.3389/fendo.2026.1837504}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- bile acids
- farnesoid X receptor
- TGR5
- gut microbiota
- glucolipid metabolism
- energy expenditure
- bile acid signaling
- bile acid homeostasis
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Yu, C., Ye, X., Zhao, H., 钱素婷, Xie, F., & Liu, Q. (2026). Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions. Frontiers in Endocrinology, 17, 1837504. https://doi.org/10.3389/fendo.2026.1837504
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Endocrinology: sign in and open the PDF from this page.
Who wrote this paper?
Chuying Yu, Xintong Ye, Haoyu Zhao, 钱素婷, Feifei Xie, Qingsheng Liu.
What is the DOI of this paper?
10.3389/fendo.2026.1837504, permanently at https://doi.org/10.3389/fendo.2026.1837504. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.